Alexandria is
convening its second mission-critical Alexandria Summit®
on Mental Health today in Washington,
DC to advance the development of novel, effective
psychiatric therapies to address vast unmet need
PASADENA, Calif., Feb. 27,
2024 /PRNewswire/ -- Alexandria Real Estate Equities,
Inc. (NYSE: ARE), the first, preeminent, longest-tenured and
pioneering owner, operator and developer of collaborative life
science mega campuses in AAA innovation cluster locations,
continues to make a distinctive, steadfast and positive impact on
the widespread and complex mental health crisis through one of the
company's bedrock social responsibility pillars that prioritizes
this unprecedented crisis. With more than 1 in 5 American adults
living with a mental illness and over 50,000 suicides in
the United States in 2023,
including over 6,000 veterans who die by suicide annually, the
nation's shared societal responsibility to drive forward treatments
and solutions to this devastating public health challenge is
immense. The National Alliance on Mental Illness estimates that
untreated mental illness represents an economic burden to the
nation of over $300 billion each year
— a number that understates the true costs of these conditions for
those afflicted as well as for their families and society.
"The staggering yet often overlooked mental health crisis in our
country is the defining public health challenge of our time. We are
very proud of the continuing tangible positive impact we have made
through our key action and results-oriented initiatives, including
our partnership with Verily, an Alphabet company, to pioneer
OneFifteen, a one-of-a-kind full continuum of care model to treat
addiction, and our crucial long-term efforts to ensure the Navy
SEAL Foundation's vital work in addressing the unique physical and
mental health needs of our nation's elite warriors," said
Joel S. Marcus, executive chairman
and founder of Alexandria Real Estate Equities, Inc. and Alexandria
Venture Investments. "We are inspired by the life science industry
and the renewed interest it is generating in developing medicines
for mental health disorders, as demonstrated by the recent
advancement of multiple psychiatric therapies, including the first
FDA-approved oral treatment for postpartum depression — from
Alexandria tenants Biogen and Sage
Therapeutics. We call for increased attention and policy action at
the federal, state and local levels to transform the way we
diagnose, treat and discuss mental illness. Our Alexandria Summit
on Mental Health will set an agenda to drive significant reform,
catalyze new mission-critical public-private partnerships and
influence policy to accelerate innovation that saves lives."
Leveraging Alexandria's
leadership position at the vanguard and heart of the $5 trillion secularly growing life science
industry and the powerful collective voice of its esteemed
Alexandria Summit community, the company, in partnership with
former congressman Patrick J.
Kennedy and The Kennedy Forum, is holding its second
mission-critical Alexandria Summit on Mental Health today in
Washington, DC. Alexandria has convened a diverse set of key
decision makers, influential life science industry thought leaders,
members of Congress, regulatory agency executives and other key
policymakers to advance the development of novel, effective
psychiatric therapies to address vast unmet need.
The Alexandria Summit on Mental Health will feature a
mission-critical panel on the creation of a public-private
partnership on biomarkers for depression, which is being led by
Alexandria through its formation
of a dedicated working group consisting of academics, innovators,
non-profits, payors, providers and biopharmaceutical executives.
The distinguished group aims to uniquely and impactfully harness
advances in biomarker development and clinical trials to develop a
modernized, data-driven and personalized framework for guiding
patients to the therapies most likely to benefit them.
Alexandria has been leveraging
deep partnerships with respected non-profits and leaders in its
world-class life science and healthcare network to break the stigma
around mental illness, promote mental health as essential to
overall health and help drive the development of safe and effective
treatments. Mental health issues often co-occur with substance use
issues, with roughly 50 percent of individuals with severe mental
disorders also impacted by addiction. In 2017, Alexandria and Verily created OneFifteen, a
first-of-its-kind evidence-based program in Dayton, Ohio that offers a full continuum of
care on a holistic campus ecosystem designed and developed by
Alexandria. Since opening in 2019,
OneFifteen has treated over 7,500 patients living with addiction
and other substance use disorders.
Military personnel and veterans experience mental health and
addiction issues at dramatically higher rates than the general U.S.
population. Since 2010, Alexandria
has been partnering with the Navy SEAL Foundation, enabling it to
address the increasing need for specialized mental health support
of Naval Special Warfare personnel and veterans. Most recently,
Alexandria played an instrumental
role in the establishment and launch of the foundation's Warrior
Fitness Program West Coast facility in San Diego. The cutting-edge facility provides
Navy SEAL warriors and veterans with evidence-based support,
advanced technology and expert personnel to help them physically
and mentally recover and rebuild from injuries and trauma.
About Alexandria Real Estate Equities, Inc.
Alexandria
Real Estate Equities, Inc. (NYSE: ARE), an S&P
500® company, is a best-in-class, mission-driven
life science REIT making a positive and lasting impact on the
world. As the pioneer of the life science real estate niche since
our founding in 1994, Alexandria
is the preeminent and longest-tenured owner, operator and developer
of collaborative life science mega campuses in AAA innovation
cluster locations, including Greater
Boston, the San Francisco Bay
Area, New York City,
San Diego, Seattle, Maryland and Research Triangle. Alexandria has a total market capitalization
of $33.1 billion and an asset base in
North America of 73.5 million SF
as of December 31, 2023, which
includes 42.0 million RSF of operating properties, 5.5 million RSF
of Class A/A+ properties undergoing construction and one near-term
project expected to commence construction in the next two years,
2.1 million RSF of priority anticipated development and
redevelopment projects and 23.9 million SF of future development
projects. Alexandria has a
longstanding and proven track record of developing Class A/A+
properties clustered in life science mega campuses that provide our
innovative tenants with highly dynamic and collaborative
environments that enhance their ability to successfully recruit and
retain world-class talent and inspire productivity, efficiency,
creativity and success. Alexandria
also provides strategic capital to transformative life science and
agrifoodtech companies through our venture capital platform. We
believe our unique business model and diligent underwriting ensure
a high-quality and diverse tenant base that results in higher
occupancy levels, longer lease terms, higher rental income, higher
returns and greater long-term asset value. For more information on
Alexandria, please
visit www.are.com.
Forward-Looking Statements
This press release includes
"forward-looking statements" within the meaning of Section 27A of
the Securities Act of 1933, as amended, and Section 21E of the
Securities Exchange Act of 1934, as amended. Such forward-looking
statements include, without limitation, statements regarding the
impact of Alexandria's social
responsibility and thought leadership initiatives, practices,
investments and progress, the likelihood of continued support,
investment and partnership by Alexandria and the potential impacts of such
activities on Alexandria's
business and tenants, the companies and non-profit organizations in
which Alexandria invests or with
which Alexandria has strategic
relationships, therapies for mental health disorders and the
country's addiction and mental health crises. These forward-looking
statements are based on Alexandria's present intent, beliefs or
expectations, but forward-looking statements are not guaranteed to
occur and may not occur. Actual results may differ materially from
those contained in or implied by Alexandria's forward-looking statements as a
result of a variety of factors, including, without limitation, the
risks and uncertainties detailed in its filings with the Securities
and Exchange Commission. All forward-looking statements are made as
of the date of this press release, and Alexandria assumes no obligation to update
this information. For more discussion relating to risks and
uncertainties that could cause actual results to differ materially
from those anticipated in Alexandria's forward-looking statements, and
risks and uncertainties to Alexandria's business in general, please refer
to Alexandria's filings with the
Securities and Exchange Commission, including its most recent
annual report on Form 10-K and any subsequently filed quarterly
reports on Form 10-Q.
CONTACT: Courtney Mulligan,
Assistant Vice President – Corporate Social Responsibility &
Strategic Communications, (646) 381-5821, cmulligan@are.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/alexandria-real-estate-equities-inc-continues-its-distinctive-steadfast-and-positive-impact-on-the-widespread-and-complex-mental-health-crisis-302071515.html
SOURCE Alexandria Real Estate Equities, Inc.